Neurelis, Inc. logo — company profile

Neurelis, Inc.

Founded 2007 United States San Diego, United States 181 employees Series D Total: $206.08M Biotechnology, Health Care +1

General Information

Company Name Neurelis, Inc.
Founded Year 2007
Location United States San Diego, United States
Employees 181
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Series D
Social

BounceWatch is an independent company data service, not affiliated with Neurelis, Inc.. To contact Neurelis, Inc., visit neurelis.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Neurelis, Inc. compare?

A PDF of Neurelis, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Neurelis, Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Neurelis, Inc.

Neurelis, Inc. is a biotechnology, healthcare, and pharmaceutical company founded in 2007 in the United States. The company is dedicated to innovating life-changing therapeutics that help people with neurological conditions gain greater control over their journeys. Neurelis recently secured a significant $114.00M Series D investment on 10 March 2021. The investors in this round included HBM Healthcare Investments, Cormorant Asset Management, Decheng Capital, LYZZ CAPITAL, and Philos & Partners. With a strong focus on neurological conditions, Neurelis is positioned to make a meaningful impact in the biotechnology and healthcare industries.

Business keywords: Neurology, Pharmaceuticals, Epilepsy, Central Nervous System, Therapeutics, Innovation, Specialty pharmaceuticals, Medical technology, Patient care, Medical innovation

Funding Rounds & Investors (9)

View All
Funding Stage Amount Investors Lead Investors Date
Series D $114.00M 5
HBM Healthcare Investments, Decheng Capital +3
10 Mar 2021
Series C Undisclosed 1
HBM Healthcare Investments
06 Oct 2020
Venture Round $40.50M -
08 Nov 2018
Debt Financing $5.20M -
24 Aug 2018
Series B $42.10M 2
HBM Healthcare Investments, LYZZ CAPITAL
05 Jan 2017
Series A Undisclosed 1
LYZZ CAPITAL
22 Feb 2016
Venture Round $1.50M -
02 Jul 2015
Debt Financing $1.08M -
03 Oct 2011
Debt Financing $1.70M -
03 Feb 2010

Neurelis, Inc. Alternatives & Competitors

View All Alternatives
Neurelis, Inc. vs

A clinical stage pharmaceutical company developing innovative treatments for neurological disease.

Series C
22 employees
Biotechnology, Health Care
Neurelis, Inc. vs

Pioneering new treatments for Central Nervous System disorders from San Jose, California.

Venture round
22 employees
Biotechnology, Health and Wellness
Neurelis, Inc. vs

R&D pharma dedicated to developing innovative medicines to treat patients suffering from Central ner...

Grant
12 employees
Biotechnology, Health Care

FAQ About Neurelis, Inc.

Neurelis, Inc., is dedicated to innovating life-changing therapeutics that help people with neurological conditions gain greater control over their journeys.
Neurelis, Inc. was founded in 2007.
Neurelis, Inc. is headquartered in San Diego, United States.
Neurelis, Inc. operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on Neurology, Pharmaceuticals, Epilepsy and Central Nervous System.
Neurelis, Inc. has approximately 181 employees.
Neurelis, Inc. has completed 9 funding rounds, raising a total of $206.08M. The latest funding stage is Series D.
Top alternatives and competitors to Neurelis, Inc. include Cerebral Therapeutics, Inc., Neurolink, Accure Therapeutics, UCB, EVER Pharma. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Neurelis, Inc. and Cerebral Therapeutics, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Neurelis, Inc., https://bouncewatch.com/company/neurelis-inc, updated 25 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes